title: Radioimmunotherapy of ovarian cancer with radiolabelled monoclonal antibodies: biological basis, present status and future perspectives.
authors.affiliation: Nuclear Medicine Division, Istituto, Nazionale per lo Studio e la Cura dei Tumouri, Milan, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Bombardieri
authors.forename: L
authors.initials: L
authors.lastname: Ferrari
authors.forename: A
authors.initials: A
authors.lastname: Spinelli
authors.forename: L
authors.initials: L
authors.lastname: Maffioli
authors.forename: E
authors.initials: E
authors.lastname: Seregni
authors.forename: G
authors.initials: G
authors.lastname: Buraggi
mesh_terms: D000911:Antibodies, Monoclonal; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007132:Immunoglobulin Isotypes; D010051:Ovarian Neoplasms / Q000532:radiotherapy*; D016499:Radioimmunotherapy
chemical_list: D000911:Antibodies, Monoclonal; D007132:Immunoglobulin Isotypes